Neuroprotection caused by hyperoxia preconditioning in animal stroke models

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 403-411

  Bigdeli, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

Author keywords

Hyperoxia; Ischemia; Neuroprotection; Stroke

Indexed keywords

ACTIVATED PROTEIN C; ENDOTHELIN;

BRAIN ISCHEMIA; CELL DEATH; CELL MEMBRANE; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; GENE EXPRESSION; HYPEROXIA; ISCHEMIC PRECONDITIONING; LYSOSOME; MIDDLE CEREBRAL ARTERY OCCLUSION; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; REVIEW; STROKE;

ANIMALS; DISEASE MODELS, ANIMAL; ISCHEMIC PRECONDITIONING; MICE; RATS; STROKE;

ANIMALIA; MUS; RATTUS;

EID: 79952388261     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.23     Document Type: Review

References (136)

1. Bigdeli, M.R., Hajizadeh, S., Froozandeh, M., Rasulian, B., Heidarianpour, A., and Khoshbaten, A. (2007) Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue. Brain Res. 1152, 228-233. (Pubitemid 46802516)
2. Leung, J.W., Chung, S.S., and Chung, S.K. (2009) Endothelial endothelin-1 over-expression using receptor tyrosine kinase tie-1 promoter leads to more severe vascular permeability and blood brain barrier breakdown after transient middle cerebral artery occlusion. Brain Res. 1266, 121-129.
3. Lampl, Y., Fleminger, G., Gilad, R., Galron, R., Sarova-Pinhas, I., and Sokolovsky, M. (1997) Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke 28(10), 1951-1955. (Pubitemid 27459002)
4. Kinouchi, H., Epstein, C.J., Mizui, T., Carlson, E., Chen, S.F., and Chan, P.H. (1991) Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 88(24), 11158-11162.
5. Bigdeli, M.R. (2009) Preconditioning with prolonged normobaric hyperoxia induces ischemic tolerance partly by upregulation of antioxidant enzymes in rat brain tissue. Brain Res. 1260, 47-54.
6. Fridovich, I. (1986) Biological effects of the superoxide radical. Arch. Biochem. Biophys. 247(1), 1-11.
7. Bigdeli, M.R., Rasoulian, B., and Meratan, A.A. (2009) In vivo normobaric hyperoxia preconditioning induces different degrees of antioxidant enzymes activities in rat brain tissue. Eur. J. Pharmacol. 611(1-3), 22-29.
8. Bigdeli, M.R., Rahnema, M., and Khoshbaten, A. (2009) Preconditioning with sublethal ischemia or intermittent normobaric hyperoxia up-regulates glutamate transporters and tumor necrosis factor-alpha converting enzyme in the rat brain. J. Stroke Cerebrovasc. Dis. 18(5), 336-342.
9. Orrenius, S., McCabe, M.J., and Nicotera, P. (1992) Ca (2+)-dependent mechanisms of cytotoxicity and programmed cell death. Toxicol. Lett. 64-65(Spec No), 357-364. (Pubitemid 23018774)
10. Brown, R.C. and Davis, T.P. (2002) Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke 33(6), 1706-1711. (Pubitemid 34619982)
11. Kitagawa, K., Matsumoto, M., Tagaya, M., Hata, R., Ueda, H., Niinobe, M., Handa, N., Fukunaga, R., Kimura, K., and Mikoshiba, K. (1990) 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 528(1), 21-24. (Pubitemid 20292932)
12. Rasoulian, B., Mohammadhosseniakbari, H., Kadkhodaee, M., Mofid, M., Baqeri, G., Bigdeli, M.R., Ghasemi, A., Mohebbi, H.A., Asgari, A., and Khoshbaten, A. (2008) Preconditioning with oxygen attenuates rat renal ischemia-reperfusion injury. J. Surg. Res. 146(2), 282-288. (Pubitemid 351484132)
13. Rasoulian, B., Jafari, M., Mahbod, M., Dehaj, M.E., Nowrozi, M., Wahhabaghai, H., Mofid, M., Ghasemi, A., Bigdeli, M.R., and Khoshbaten, A. (2010) Pretreatment with oxygen protects rat kidney from cisplatin nephrotoxicity. Ren. Fail. 32(2), 234-242.
14. Gidday, J.M., Fitzgibbons, J.C., Shah, A.R., and Park, T.S. (1994) Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci. Lett. 168(1-2), 221-224. (Pubitemid 24097362)
15. Toyoda, T., Kassell, N.F., and Lee, K.S. (2000) Induction of tolerance against ischemia-reperfusion injury in the rat brain by preconditioning with the endotoxin analog diphosphoryl lipid A. J. Neurosurg. 92(3), 435-441. (Pubitemid 30112384)
16. Perez-Pinzon, M.A. (2007) Mechanisms of neuroprotection during ischemic preconditioning: lessons from anoxic tolerance. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 147(2), 291-299.
17. Ohtsuki, T., Matsumoto, M., Kuwabara, K., Kitagawa, K., Suzuki, K., Taniguchi, N., and Kamada, T. (1992) Influence of oxidative stress on induced tolerance to ischemia in gerbil hippocampal neurons. Brain Res. 599(2), 246-252. (Pubitemid 23030221)
18. Riepe, M.W. and Ludolph, A.C. (1997) Chemical preconditioning: a cytoprotective strategy. Mol. Cell. Biochem. 174(1-2), 249-254. (Pubitemid 127739059)
19. Bigdeli, M.R. and Khoshbaten, A. (2008) In vivo preconditioning with normobaric hyperoxia induces ischemic tolerance partly by triggering tumor necrosis factor-alpha converting enzyme/tumor necrosis factor-alpha/nuclear factor-kappaB. Neuroscience 153(3), 671-678.
20. Günther, A., Küppers-Tiedt, L., Schneider, P.M., Kunert, I., Berrouschot, J., Schneider, D., and Rossner, S. (2005) Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia. Eur. J. Neurosci. 21(11), 3189-3194. (Pubitemid 40917079)
21. Ravati, A., Ahlemeyer, B., Becker, A., Klumpp, S., and Krieglstein, J. (2001) Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-kappaB. J. Neurochem. 78(4), 909-919. (Pubitemid 32777991)
22. Wada, K., Miyazawa, T., Nomura, N., Yano, A., Tsuzuki, N., Nawashiro, H., and Shima, K. (2000) Mn-SOD and Bcl-2 expression after repeated hyperbaric oxygenation. Acta Neurochir. Suppl. 76, 285-290.
23. Grabb, M.C. and Choi, D.W. (1999) Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J. Neurosci. 19(5), 1657-1662. (Pubitemid 29094184)
24. Shimazaki, K., Ishida, A., and Kawai, N. (1994) Increase in bcl-2 oncoprotein and the tolerance to ischemia-induced neuronal death in the gerbil hippocampus. Neurosci. Res. 20(1), 95-99. (Pubitemid 24262422)
25. Ohtsuki, T., Ruetzler, C.A., Tasaki, K., and Hallenbeck, J.M. (1996) Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. J. Cereb. Blood Flow Metab. 16(6), 1137-1142. (Pubitemid 26365364)
26. Gonzalez-Zulueta, M., Feldman, A.B., Klesse, L.J., Kalb, R.G., Dillman, J.F., Parada, L.F., Dawson, T.M., and Dawson, V.L. (2000) Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc. Natl. Acad. Sci. U. S. A. 97(1), 436-441. (Pubitemid 30055849)
27. Trendelenburg, G., Prass, K., Priller, J., Kapinya, K., Polley, A., Muselmann, C., Ruscher, K., Kannbley, U., Schmitt, A.O., Castell, S., Wiegand, F., Meisel, A., Rosenthal, A., and Dirnagl, U. (2002) Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J. Neurosci. 22(14), 5879-5888. (Pubitemid 35387632)
28. Wick, A., Wick, W., Waltenberger, J., Weller, M., Dichgans, J., and Schulz, J.B. (2002) Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J. Neurosci. 22(15), 6401-6407. (Pubitemid 35386396)
29. Ruscher, K., Freyer, D., Karsch, M., Isaev, N., Megow, D., Sawitzki, B., Priller, J., Dirnagl, U., and Meisel, A. (2002) Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22(23), 10291-10301. (Pubitemid 35416867)
30. McLaughlin, B. (2004) The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodeling. Apoptosis 9(2), 111-121.
31. Mattson, M.P. and Wan, R. (2005) Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J. Nutr. Biochem. 16(3), 129-137. (Pubitemid 40312164)
32. Singhal, A.B. (2007) A review of oxygen therapy in ischemic stroke. Neurol. Res. 29(2), 173-183.
33. Flynn, E.P. and Auer, R.N. (2002) Eubaric hyperoxemia and experimental cerebral infarction. Ann. Neurol. 52(5), 566-572. (Pubitemid 35246859)
34. Edwards, M., Kent, T.A., Rea, H.C., Wei, J., Quast, M., Izumi, T., Mitra, S., and Perez-Polo, J.R. (1998) APE/Ref-1 responses to ischemia in rat brain. Neuroreport 9(18), 4015-4018. (Pubitemid 29030680)
35. Abbruscato, T.J., Lopez, S.P., Roder, K., and Paulson, J.R. (2004) Regulation of blood-brain barrier Na,K,2Cl-cotransporter through phosphorylation during in vitro stroke conditions and nicotine exposure. J. Pharmacol. Exp. Ther. 310(2), 459-468. (Pubitemid 38988888)
36. Kalaria, R.N., Low, W.C., Oakley, A.E., Slade, J.Y., Ince, P.G., Morris, C.M., and Mizuno, T. (2002) CADASIL and genetics of cerebral ischaemia. J. Neural Transm. Suppl. (63), 75-90. (Pubitemid 38471310)
37. Pan, J.W., Hetherington, H.P., Vaughan, J.T., Mitchell, G., Pohost, G.M., and Whitaker, J.N. (1996) Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T. Magn. Reson. Med. 36(1), 72-77. (Pubitemid 26196534)
38. Huber, R., Kasischke, K., Ludolph, A.C., and Riepe, M.W. (1999) Increase of cellular hypoxic tolerance by erythromycin and other antibiotics. Neuroreport 10(7), 1543-1546. (Pubitemid 29354343)
39. Das, D.K., Engelman, R.M., and Maulik, N. (1999) Oxygen free radical signaling in ischemic preconditioning. Ann. N. Y. Acad. Sci. 874, 49-65. (Pubitemid 29351930)
40. Van de Wouwer, M., Collen, D., and Conway, E.M. (2004) Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler. Thromb. Vasc. Biol. 24(8), 1374-1383. (Pubitemid 39050428)
41. Bogatcheva, N.V., Garcia, J.G., and Verin, A.D. (2002) Role of tyrosine kinase signaling in endothelial cell barrier regulation. Vascul. Pharmacol. 39(4-5), 201-212. (Pubitemid 37490746)
42. Feistritzer, C., Mosheimer, B.A., Sturn, D.H., Riewald, M., Patsch, J.R., and Wiedermann, C.J. (2006) Endothelial protein C receptor-dependent inhibition of migration of human lymphocytes by protein C involves epidermal growth factor receptor. J. Immunol. 176(2), 1019-1025. (Pubitemid 43099702)
43. Coughlin, S.R. (2000) Thrombin signalling and protease-activated receptors. Nature 407(6801), 258-264.
44. Sanchez, E.C. (2007) Hyperbaric oxygenation in peripheral nerve repair and regeneration. Neurol. Res. 29(2), 184-198.
45. Kataoka, K., Hasegawa, K., Sawamura, T., Fujita, M., Yanazume, T., Iwai-Kanai, E., Kawamura, T., Hirai, T., Kita, T., and Nohara, R. (2003) LOX-1 pathway affects the extent of myocardial ischemia-reperfusion injury. Biochem. Biophys. Res. Commun. 300(3), 656-660. (Pubitemid 36268886)
46. Dömötör, E., Benzakour, O., Griffin, J.H., Yule, D., Fukudome, K., and Zlokovic, B.V. (2003) Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1. Blood 101(12), 4797-4801. (Pubitemid 36857737)
47. Yanagisawa, D., Kitamura, Y., Inden, M., Takata, K., Taniguchi, T., Morikawa, S., Morita, M., Inubushi, T., Tooyama, I., Taira, T., Iguchi-Ariga, S.M., Akaike, A., and Ariga, H. (2008) DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. J. Cereb. Blood Flow Metab. 28(3), 563-578. (Pubitemid 351304267)
48. Cattaruzza, M., Dimigen, C., Ehrenreich, H., and Hecker, M. (2000) Stretch-induced endothelin B receptor-mediated apoptosis in vascular smooth muscle cells. FASEB J. 14(7), 991-998. (Pubitemid 30241677)
49. Abbott, N.J. (2002) Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 200(6), 629-638.
50. Tsang, M.C., Lo, A.C., Cheung, P.T., Chung, S.S., and Chung, S.K. (2001) Perinatal hypoxia-/ischemia-induced endothelin-1 mRNA in astrocyte-like and endothelial cells. Neuroreport 12(10), 2265-2270. (Pubitemid 32646285)
51. Callaway, J.K., Knight, M.J., Watkins, D.J., Beart, P.M., and Jarrott, B. (1999) Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats. Stroke 30(12), 2704-2712; discussion 2712.
52. Traystman, R.J., Kirsch, J.R., and Koehler, R.C. (1991) Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J. Appl. Physiol. 71(4), 1185-1195.
53. Dirnagl, U., Iadecola, C., and Moskowitz, M.A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22(9), 391-397. (Pubitemid 29453643)
54. Felx, M., Guyot, M.C., Isler, M., Turcotte, R.E., Doyon, J., Khatib, A.M., Leclerc, S., Moreau, A., and Moldovan, F. (2006) Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma. Clin. Sci. (Lond.) 110(6), 645-654. (Pubitemid 43844734)
55. Shichiri, M., Kato, H., Marumo, F., and Hirata, Y. (1997) Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension 30(5), 1198-1203. (Pubitemid 27476179)
56. Zhang, R.L., Zhang, C., Zhang, L., Roberts, C., Lu, M., Kapke, A., Cui, Y., Ninomiya, M., Nagafuji, T., Albala, B., Zhang, Z.G., and Chopp, M. (2008) Synergistic effect of an endothelin type A receptor antagonist, S-0139, with rtPA on the neuroprotection after embolic stroke. Stroke 39(10), 2830-2836.
57. Ishihara, H., Kubota, H., Lindberg, R.L., Leppert, D., Gloor, S.M., Errede, M., Virgintino, D., Fontana, A., Yonekawa, Y., and Frei, K. (2008) Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins. J. Neuropathol. Exp. Neurol. 67(5), 435-448. (Pubitemid 351653535)
58. Ho, M.C., Lo, A.C., Kurihara, H., Yu, A.C., Chung, S.S., and Chung, S.K. (2001) Endothelin-1 protects astrocytes from hypoxic/ischemic injury. FASEB J. 15(3), 618-626. (Pubitemid 32245980)
59. Bigdeli, M.R., Hajizadeh, S., Froozandeh, M., Heidarianpour, A., Rasoulian, B., Asgari, A.R., Pourkhalili, K., and Khoshbaten, A. (2008) Normobaric hyperoxia induces ischemic tolerance and upregulation of glutamate transporters in the rat brain and serum TNF-alpha level. Exp. Neurol. 212(2), 298-306.
60. Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., et al. (2003) Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424(6948), 516-523. (Pubitemid 36975769)
61. Chiarugi, A. and Moskowitz, M.A. (2002) PARP-1 a perpetrator of apoptotic cell death? Science 297(5579), 259-263.
62. Fesik, S.W. and Shi, Y. (2001). Structural biology. Controlling the caspases. Science 294(5546), 1477-1478.
63. Tong, L., Toliver-Kinsky, T., Rassin, D., Werrbach-Perez, K., and Perez-Polo, J.R. (2003) Hyperoxia increases AP-1 DNA binding in rat brain. Neurochem. Res. 28(1), 111-115. (Pubitemid 36173232)
64. O'Rourke, B. (2004) Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ. Res. 94(4), 420-32.
65. Pain, T., Yang, X.M., Critz, S.D., Yue, Y., Nakano, A., Liu, G.S., Heusch, G., Cohen, M.V., and Downey, J.M. (2000) Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ. Res. 87(6), 460-466.
66. Lou, M., Chen, Y., Ding, M., Eschenfelder, C.C., and Deuschl, G. (2006) Involvement of the mitochondrial ATP-sensitive potassium channel in the neuroprotective effect of hyperbaric oxygenation after cerebral ischemia. Brain Res. Bull. 69(2), 109-116. (Pubitemid 43375864)
67. Daugherty, W.P., Levasseur, J.E., Sun, D., Rockswold, G.L., and Bullock, M.R. (2004) Effects of hyperbaric oxygen therapy on cerebral oxygenation and mitochondrial function following moderate lateral fluid-percussion injury in rats. J. Neurosurg. 101(3), 499-504. (Pubitemid 39100727)
68. Vlodavsky, E., Palzur, E., and Soustiel, J.F. (2006) Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury. Neuropathol. Appl. Neurobiol. 32(1), 40-50.
69. Palzur, E., Vlodavsky, E., Mulla, H., Arieli, R., Feinsod, M., and Soustiel, J.F. (2004) Hyperbaric oxygen therapy for reduction of secondary brain damage in head injury: an animal model of brain contusion. J. Neurotrauma 21(1), 41-48. (Pubitemid 38141801)
70. Vlodavsky, E., Palzur, E., Feinsod, M., and Soustiel, J.F. (2005) Evaluation of the apoptosis-related proteins of the BCL-2 family in the traumatic penumbra area of the rat model of cerebral contusion, treated by hyperbaric oxygen therapy: a quantitative immunohistochemical study. Acta Neuropathol. 110(2), 120-126. (Pubitemid 41245200)
71. Choi, D.W. and Rothman, S.M. (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13, 171-182. (Pubitemid 20100647)
72. Grabb, M.C., Lobner, D., Turetsky, D.M., and Choi, D.W. (2002) Preconditioned resistance to oxygen-glucose deprivation-induced cortical neuronal death: alterations in vesicular GABA and glutamate release. Neuroscience 115(1), 173-183. (Pubitemid 35232699)
73. Romera, C., Hurtado, O., Botella, S.H., Lizasoain, I., Cárdenas, A., Fernández-Tomé, P., Leza, J.C., Lorenzo, P., and Moro, M.A. (2004) In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway. J. Neurosci. 24(6), 1350-1357. (Pubitemid 38222985)
74. Pradillo, J.M., Hurtado, O., Romera, C., Cárdenas, A., Fernández-Tomé, P., Alonso-Escolano, D., Lorenzo, P., Moro, M.A., and Lizasoain, I. (2008) TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning. Neuroscience 138(4), 1171-1178. (Pubitemid 43363535)
75. Takahashi, M., Billups, B., Rossi, D., Sarantis, M., Hamann, M., and Attwell, D. (1997) The role of glutamate transporters in glutamate homeostasis in the brain. J. Exp. Biol. 200(2), 401-409. (Pubitemid 27126472)
76. Maragakis, N.J. and Rothstein, J.D. (2004) Glutamate transporters: animal models to neurologic disease. Neurobiol. Dis. 15(3), 461-473. (Pubitemid 38429961)
77. Seal, R.P. and Amara, S.G. (1999) Excitatory amino acid transporters: a family in flux. Annu. Rev. Pharmacol. Toxicol. 39, 431-456. (Pubitemid 29222566)
78. Yamashita, A., Makita, K., Kuroiwa, T., and Tanaka, K. (2006) Glutamate transporters GLAST and EAAT4 regulate postischemic Purkinje cell death: an in vivo study using a cardiac arrest model in mice lacking GLAST or EAAT4. Neurosci. Res. 55(3), 264-270. (Pubitemid 43766408)
79. Robinson, M.B. (1998) The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype. Neurochem. Int. 33(6), 479-491.
80. Namura, S., Maeno, H., Takami, S., Jiang, X.F., Kamichi, S., Wada, K., and Nagata, I. (2002) Inhibition of glial glutamate transporter GLT-1 augments brain edema after transient focal cerebral ischemia in mice. Neurosci. Lett. 324(2), 117-120. (Pubitemid 34457818)
81. Aoyama, K., Suh, S.W., Hamby, A.M., Liu, J., Chan, W.Y., Chen, Y., and Swanson, R.A. (2006) Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat. Neurosci. 9(1), 119-126. (Pubitemid 43011917)
82. Skeberdis, V.A., Lan, J., Opitz, T., Zheng, X., Bennett, M.V., and Zukin, R.S. (2001) mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology 40(7), 856-865. (Pubitemid 32510799)
83. Bonsi, P., Cuomo, D., De Persis, C., Centonze, D., Bernardi, G., Calabresi, P., and Pisani, A. (2005) Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons. Neuropharmacology 49(Suppl 1), 104-113. (Pubitemid 41115897)
84. Abe, K. and Takeichi, M. (2007) NMDA-receptor activation induces calpain-mediated beta-catenin cleavages for triggering gene expression. Neuron 53(3), 387-397. (Pubitemid 46178410)
85. Hurtado, O., Cárdenas, A., Lizasoain, I., Boscá, L., Leza, J.C., Lorenzo, P., and Moro, M.A. (2001) Up-regulation of TNF-alpha convertase (TACE/ADAM17) after oxygen-glucose deprivation in rat forebrain slices. Neuropharmacology 40(8), 1094-1102. (Pubitemid 32530616)
86. Hurtado, O., Lizasoain, I., Fernández-Tomé, P., Alvarez-Barrientos, A., Leza, J.C., Lorenzo, P., and Moro, M.A. (2002) TACE/ADAM17-TNF-alpha pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate. J. Cereb. Blood Flow Metab. 22(5), 576-585. (Pubitemid 34477779)
87. Hao, Q. and Maret, W. (2005) Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease. J. Alzheimers Dis. 8(2), 161-170. (Pubitemid 43230133)
88. Choi, H., Kim, S.H., Chun, Y.S., Cho, Y.S., Park, J.W., and Kim, M.S. (2006) In vivo hyperoxic preconditioning prevents myocardial infarction by expressing bcl-2. Exp. Biol. Med. (Maywood) 231(4), 463-472.
89. Maulik, N., Yoshida, T., Zu, Y.L., Sato, M., Banerjee, A., and Das, D.K. (1998) Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2. Am. J. Physiol. 275(5 Pt 2), H1857-64.
90. Pourkhalili, K., Hajizadeh, S., Tiraihi, T., Akbari, Z., Esmailidehaj, M., Bigdeli, M.R., and Khoshbaten, A. (2009) Ischemia and reperfusion-induced arrhythmias: role of hyperoxic preconditioning. J. Cardiovasc. Med. (Hagerstown) 10(8), 635-642.
91. Xuan, B., Zhou, Y.H., Varma, R., and Chiou, G.C. (1999) Effects of some N-nitropyrazole derivatives on ocular blood flow and retinal function recovery after ischemic insult. J. Ocul. Pharmacol. Ther. 15(2), 135-142. (Pubitemid 29183584)
92. Madrigal, J.L., García-Bueno, B., Caso, J.R., Pérez-Nievas, B.G., and Leza. J.C. (2006) Stress-induced oxidative changes in brain. CNS Neurol. Disord. Drug Targets 5(5), 561-568. (Pubitemid 44523873)
93. Li, N. and Karin, M. (1999) Is NF-kappaB the sensor of oxidative stress? FASEB J. 13(10), 1137-1143.
94. Natoli, G., Costanzo, A., Guido, F., Moretti, F., and Levrero, M. (1998) Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis fac-tor signalling. Biochem. Pharmacol. 56, 915-920. (Pubitemid 28454555)
95. Ashkenazi, A. and Dixit, V.M. (1999) Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11(2), 255-260. (Pubitemid 29164042)
96. Cardenas, A., Moro, M., Leza, J., Oshea, E., Davalos, A., Castillo, J., Lorenzo, P., and Lizasoain, I. (2002) Upregulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance. J. Cereb. Blood Flow Metab. 22, 1297-1302. (Pubitemid 35285086)
97. Ginis, I., Jaiswal, R., Klimanis, D., Liu, J., Greenspon, J., and Hallenbeck, J.M. (2002) TNF-alpha-induced tolerance to ischemic injury involves differential control of NF-kappaB transactivation: the role of NF-kappaB association with p300 adaptor. J. Cereb. Blood Flow Metab. 22(2), 142-152. (Pubitemid 34135645)
98. Park, D.S., Morris, E.J., Greene, L.A., and Geller, H.M. (1997) G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J. Neurosci. 17, 1256-1270. (Pubitemid 27073728)
99. Martindale, J.L. and Holbrook, N.J. (2002) Cellular response to oxidative stress: signaling for suicide and survival. Cell Physiol. 192(1), 1-15. (Pubitemid 34587382)
100. Ozes, O.N., Mayo, L.D., Gustin, J.A., Pfeffer, S.R., Pfeffer, L.M., and Donner, D.B. (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401(6748), 82-85.
101. Potrovita, I., Zhang, W., Burkly, L., Hahm, K., Lincecum, J., Wang, M.Z., Maurer, M.H., Rossner, M., Schneider, A., and Schwaninger, M. (2004) Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration. Neurosci. 24(38), 8237-8244. (Pubitemid 39280803)
102. Perkins, N.D. and Gilmore, T.D. (2006) Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ. 13(5), 759-72.
103. Ryan, K.M., Ernst, M.K., Rice, N.R., and Vousden, K.H. (2000) Role of NF-kB in p53-mediated programmed cell death. Nature 404, 892-897. (Pubitemid 30230343)
104. Crack, P.J. and Taylor, J.M. (2005) Reactive oxygen species and the modulation of stroke. Free Radic. Biol. Med. 38(11), 1433-1444. (Pubitemid 40693828)
105. Kane, D.J., Sarafian, T.A., Anton, R., Hahn, H., Gralla, E.B., Valentine, J.S., Ord, T., and Bredesen, D.E. (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262, 1274-1277. (Pubitemid 24036095)
106. Murphy, S.J., Song, D., Welsh, F.A., Wilson, D.F., and Pastuszko, A. (1999) Regional expression of heat shock protein 72 mRNA following mild and severe hypoxia in neonatal piglet brain. Adv. Exp. Med. Biol. 471, 155-163.
107. Kroemer, G., Dallaporta, B., and Resche-Rigon, M. (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60, 619-642. (Pubitemid 28157889)
108. Coyle, J.T. and Puttfarcken, P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262(5134), 689-695. (Pubitemid 23350687)
109. Basaga, H.S. (1990) Biochemical aspects of free radicals. Biochem. Cell Biol. 68(7-8), 989-998.
110. Leong, K.G. and Karsan, A. (2000) Signaling pathways mediated by tumor necrosis factor a. Histol. Histopathol. 15, 1303-1325.
111. Coward, W.R., Okayama, Y., Sagara, H., Wilson, S.J., Holgate, S.T., and Church, M.K. (2002) NF-kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells? J. Immunol. 169, 5287-5293. (Pubitemid 35217201)
112. Okado-Matsumoto, A. and Fridovich, I. (2001) Subcellular distribution of superoxide dismutases (SOD) in rat liver. J. Biol. Chem. 276, 38388-38393.
113. Marklund, S.L. (1984) Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem. J. 222, 649-655.
114. Yang, G., Chan, P.H., Chen, J., Carlson, E., Chen, S.F., Weinstein, P., Epstein, C.J., and Kamii, H. (1994) Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25, 165-170.
115. Noshita, N., Sugawara, T., Hayashi, T., Lewen, A., Omar, G., and Chan, P.H. (2002) Copper/zinc superoxide dismutase attenuates neuronal cell death by preventing extracellular signal-regulated kinase activation after transient focal cerebral ischemia in mice. J. Neurosci. 22, 7923-7930. (Pubitemid 35379097)
116. Saito, A., Hayashi, T., Okuno, S., Ferrand-Drake, M., and Chan, P.H. (2003) Overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. J. Neurosci. 23, 1710-1718. (Pubitemid 36314726)
117. Sugawara, T., Noshita, N., Lewen, A., Gasche, Y., Ferrand-Drake, M., Fujimura, M., Morita-Fujimura, Y., and Chan, P.H. (2002) Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J. Neurosci. 22, 209-217. (Pubitemid 34036536)
118. Fujimura, M., Morita-Fujimura, Y., Narasimhan, P., Copin, J.C., Kawase, M., and Chan, P.H. (1999) Copper-zinc superoxide dismutase prevents the early decrease of apurinic/apyrimidinic endonuclease and subsequent DNA fragmentation after transient focalcerebral ischemia in mice. Stroke 30, 2408-2415. (Pubitemid 29517742)
119. Ostrowski, R., Colohan, A., and Zhang, J. (2005) Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 25, 554-571. (Pubitemid 40562929)
120. Warner, D., Sheng, H., and Batinic-Haberle, I. (2004) Oxidants, antioxidants and the ischemic brain. J. Exp. Biol. 207, 3221-3231. (Pubitemid 39275296)
121. Marklund, S.L., Holme, E., and Hellner, L. (1982) Superoxide dismutase in extracellular fluids. Clin. Chim. Acta 126, 41-51. (Pubitemid 13242364)
122. Namba, K., Takeda, Y., Sunami, K., and Hirakawa, M. (2001) Temporal profiles of the levels of endogenous antioxidants after four-vessel occlusion in rats. J. Neurosurg. Anesthesiol. 13, 131-137. (Pubitemid 32244989)
123. Li, J., Liu, W., Ding, S., Xu, W., Guan, Y., Zhang, J.H., and Sun, X. (2008) Hyperbaric oxygen preconditioning induces tolerance against brain ischemia-reperfusion injury by upregulation of antioxidant enzymes in rats. Brain Res. 1210, 223-229.
124. Ember, J.A., del Zoppo, G.J., Mori, E., Thomas, W.S., Copeland, B.R., and Hugli, T.E. (1994) Polymorphonuclear leukocyte behavior in a nonhuman primate focal ischemia model. J. Cereb. Blood Flow Metab. 14(6), 1046-1054. (Pubitemid 24332950)
125. Miljkovic-Lolic, M., Silbergleit, R., Fiskum, G., and Rosenthal, R.E. (2003) Neuroprotective effects of hyperbaric oxygen treatment in experimental focal cerebral ischemia are associated with reduced brain leukocyte myeloperoxidase activity. Brain Res. 971(1), 90-94. (Pubitemid 36412067)
126. Buras, J.A. and Reenstra, W.R. (2007) Endothelial-neutrophil interactions during ischemia and reperfusion injury: basic mechanisms of hyperbaric oxygen. Neurol Res. 29(2), 127-131. (Pubitemid 46685265)
127. Thom, SR. (1993) Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats. Toxicol. Appl. Pharmacol. 123(2), 248-256.
128. Richards, E.M., Fiskum, G., Rosenthal, R.E., Hopkins, I., and McKenna, M.C. (2007) Hyperoxic reperfusion after global ischemia decreases hippocampal energy metabolism. Stroke 38(5), 1578-1584. (Pubitemid 46684177)
129. Warburton, D., Wuenschell, C., Flores-Delgado, G., and Anderson, K. (1998) Commitment and differentiation of lung cell lineages. Biochem. Cell Biol. 76(6), 971-995. (Pubitemid 29450565)
130. Aguirre, J.A., Kehr, J., Yoshitake, T., Liu, F.L., Rivera, A., Fernandez-Espinola, S., Andbjer, B., Leo, G., Medhurst, A.D., Agnati, L.F., and Fuxe, K. (2005) Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP. Brain Res. 1033(2), 216-220. (Pubitemid 40193417)
131. Freiberger, J.J., Suliman, H.B., Sheng, H., McAdoo, J., Piantadosi, C.A., and Warner, D.S. (2006) A comparison of hyperbaric oxygen versus hypoxic cerebral preconditioning in neonatal rats. Brain Res. 1075(1), 213-222.
132. Helms, A., Whelan, H., and Torbey, M. (2005) Hyperbaric oxygen therapy of cerebral ischemia. Cerebrovasc. Dis. 20, 417-426. (Pubitemid 41675018)
133. Zhang, R.L., Chopp, M., Jiang, N., Tang, W.X., Prostak, J., Manning, A.M., and Anderson, D.C. (1995) Antiintercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 26(8), 1438-1442.
134. Bowes, M.P., Zivin, J.A., and Rothlein, R. (1993) Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp. Neurol. 119(2), 215-219. (Pubitemid 23132018)
135. Liu, W., Sood, R., Chen, Q., Sakoglu, U., Hendren, J., Cetin, O., Miyake, M., and Liu, K.J. (2008) Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke. J. Neurochem. 107(5), 1196-1205.
136. Liu, W., Hendren, J., Qin, X.J., Shen, J., and Liu, K.J. (2009) Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J. Neurochem. 108(3), 811-820.